BaseLaunch Information

BaseLaunch is the Basel-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. It serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operationally run and financed by Basel Area Business & Innovation, the investment and innovation promotion agency helping companies, institutions and startups find business success in the Basel area. BaseLaunch partners with leading global pharma and biotech companies and a venture fund – AbbVie, Roche, Novo Nordisk, Johnson & Johnson, CSL, Pfizer, Takeda, and Pureos Bioventures, which also feed into the pool out of which BaseLaunch funds ventures. Domain and regional partners include KPMG, Vossius & Partner, Walder Wyss attorneys at law, WuXi AppTec, Lonza, Charles River Laboratories, Wuxi Biologics, BioDuro, VISCHER, Catalent as well as the Switzerland Innovation Park Basel Area. Since 2018, BaseLaunch supported ventures have raised in total over US$ 1 billion. Harnessing the Basel area’s unique position as a global life sciences hub, as well as its rising popularity among investors, BaseLaunch is looking to attract the next generation of breakthrough companies. Interested groups can find more information at www.baselaunch.ch